2-73729997-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_016058.5(TPRKB):āc.474T>Cā(p.Ile158=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.639 in 1,566,616 control chromosomes in the GnomAD database, including 324,466 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.58 ( 26579 hom., cov: 32)
Exomes š: 0.65 ( 297887 hom. )
Consequence
TPRKB
NM_016058.5 synonymous
NM_016058.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.754
Genes affected
TPRKB (HGNC:24259): (TP53RK binding protein) Enables protein kinase binding activity. Involved in tRNA threonylcarbamoyladenosine modification. Located in cytosol and nucleus. Part of EKC/KEOPS complex. Implicated in Galloway-Mowat syndrome 5. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 2-73729997-A-G is Benign according to our data. Variant chr2-73729997-A-G is described in ClinVar as [Benign]. Clinvar id is 1253010.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.754 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.678 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPRKB | NM_016058.5 | c.474T>C | p.Ile158= | synonymous_variant | 5/5 | ENST00000272424.11 | NP_057142.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPRKB | ENST00000272424.11 | c.474T>C | p.Ile158= | synonymous_variant | 5/5 | 1 | NM_016058.5 | ENSP00000272424 | P1 |
Frequencies
GnomAD3 genomes AF: 0.576 AC: 87527AN: 151940Hom.: 26572 Cov.: 32
GnomAD3 genomes
AF:
AC:
87527
AN:
151940
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.628 AC: 140375AN: 223410Hom.: 44934 AF XY: 0.637 AC XY: 77250AN XY: 121228
GnomAD3 exomes
AF:
AC:
140375
AN:
223410
Hom.:
AF XY:
AC XY:
77250
AN XY:
121228
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.646 AC: 913885AN: 1414558Hom.: 297887 Cov.: 33 AF XY: 0.647 AC XY: 454507AN XY: 702184
GnomAD4 exome
AF:
AC:
913885
AN:
1414558
Hom.:
Cov.:
33
AF XY:
AC XY:
454507
AN XY:
702184
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.576 AC: 87572AN: 152058Hom.: 26579 Cov.: 32 AF XY: 0.582 AC XY: 43266AN XY: 74330
GnomAD4 genome
AF:
AC:
87572
AN:
152058
Hom.:
Cov.:
32
AF XY:
AC XY:
43266
AN XY:
74330
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2348
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Galloway-Mowat syndrome 5 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at